Categories: Antimicrobial Resistance, Healthcare-associated infections, Medication Safety
April 7th, 2011 6:28 am ET -
Author – Jean B. Patel, PhD, D(ABMM)
Deputy Director for CDC’s Office of Antimicrobial Resistance
CDC’s Division of Healthcare Quality Promotion
Each year, millions of Americans take antimicrobial drugs, including antibiotics. People have come to trust and rely on antibiotics to always be there to fight their worst infections. However, new drug-resistant pathogens continue to emerge, finding ways around our most powerful treatments. As the threat of untreatable infections grows, preventing the spread of antimicrobial resistant pathogens remains important.
World Health Day 2011: Help fight antimicrobial resistance
CDC joins the World Health Organization and other health partners in recognizing today as World Health Day, which this year spotlights the growing global problem of antimicrobial resistance – when germs change in a way that reduces or eliminates the effectiveness of drugs to treat them. Today’s resistant infections are often more severe, leading to longer hospital stays and increased costs for treatment.
3 Comments -
Categories: Antibiotic use, Hand Hygiene, Healthcare-associated infections
April 6th, 2011 8:17 am ET -
Steven M. Gordon, MD, FACP
Guest Author – Steven M. Gordon, MD, FACP
President of SHEA
The Society for Healthcare Epidemiology of America’s 21st Annual Meeting provided a forum for discussing the latest research, evidence and advances in healthcare epidemiology, with the goal of bringing this knowledge one step closer to bedside implementation and the elimination of healthcare-associated infections. More than 1,600 academicians, researchers, frontline providers, infection preventionists and public health officials attended the four-day event in Dallas.
Two studies that highlight the breadth of the work presented at this year’s meeting are highlighted below. The first, from researchers with the Salt Lake City VA Healthcare System, demonstrates the rising use of broad-spectrum antibiotics over a five-year period. This increased use may be impacting the efficacy of our most powerful antibiotics.
In an era of multi-drug resistant organisms, clinicians are placed in a difficult situation. Because treatment outcomes of many bacterial infections are influenced by the timing of appropriate therapy, the increasing presence of resistant organisms triggers greater use of these powerful antibiotics for proven or suspected infections in hospitalized patients. Studies like this are critical to our understanding of antibiotic resistance.
1 Comment -
Categories: BSIs, CLABSI, HICPAC, Healthcare-associated infections
April 4th, 2011 8:21 am ET -
Naomi O’Grady, MD
Guest Author – Naomi O’Grady, MD
National Institutes of Health
Medical Director, Clinical Center’s Vascular Access and Conscious Sedation Services.
Recently, hospital-acquired infections have become an important benchmark of hospital quality and patient safety. Many hospitals are now being required to report patient safety data, and some of this data includes infection rates.
I am proud to announce the release of the updated Guideline to Prevent Intravascular Catheter Related Infections. Clinicians and infection control personnel now have the most recent published information on how to best eliminate these types of infections.
2 Comments -
Categories: Healthcare-associated infections, Injection Safety
April 1st, 2011 11:21 am ET -
Amit Chitnis, MD, MPH
Author – Amit Chitnis, MD, MPH
CDC Epidemic Intelligence Officer
Division of Healthcare Quality Promotion
Today, CDC is reminding clinicians to use facemasks when injecting medicine or inserting catheters into epidural or subdural spaces of the spine. This includes “epidurals” during childbirth labor and injection of contrast dye during imaging procedures.
We are concerned that despite 2007 recommendations aimed at preventing these infections, outbreaks of infections continue to occur among patients undergoing spinal injection procedures. As a CDC Epidemic Intelligence Service Officer, I investigated the most recent outbreak of bacterial meningitis among patients who had undergone a spinal injection during the course of their medical care. Our findings from this investigation, as well as from previous CDC investigations, have helped us answer the following questions:
First, who is at risk? Anyone receiving spinal injection procedures may be at risk of contracting an infection if proper infection control techniques are not in place. In the most recent investigation, all the cases of bacterial meningitis occurred among patients who underwent myelography (a spinal procedure requiring injection of contrast dye) at an outpatient imaging facility. However, in previous investigations, cases were detected primarily among hospital patients who received spinal anesthesia or epidural anesthesia.
7 Comments -
Categories: Antimicrobial Resistance, Gram negatives, HICPAC, Healthcare-associated infections, Long Term Care (LTC)
March 29th, 2011 3:18 pm ET -
Arjun Srinivasan, MD
Author – Arjun Srinivasan, MD
CDC’s Division of Healthcare Quality Promotion
You probably have seen the media reports this week about drug-resistant infections in California healthcare facilities, specifically those in Los Angeles County. What we know, however, is that carbapenem-resistant Klebsiella pneumoniae (CRKP) actually exists in at least 36 states. Originally identified in 1999, CRKP may be present in the other 14 states as well, just not yet reported to CDC.
CRKP is a Gram-negative bacteria and part of a family called Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae (or CRE) are able to fight off our last-resort antibiotics and have become an important public health issue resulting in high mortality (death) in patients.
How can we stop these bugs? CDC released prevention guidelines on multi-drug resistant organisms in 2006 and guidelines specifically targeting CRE in 2009. [See my previous blog posts on how to prevent CRE.]
2 Comments -